ARS Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Fraud And Investors ...
NDAQ:SPRY) ARS Pharmaceuticals, Inc. Is Being Investigated For Possible Securities Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm ...
News4Jax1 天
More nasal spray medications: Are vaccines next?
Whether it’s allergies, a sinus infection or runny nose, many people turn to nasal sprays for quick relief. Now, there’s ...
ARS Pharmaceuticals更新制造协议条款
加利福尼亚州圣地亚哥 - 根据最近向美国证券交易委员会提交的8-K文件，专门从事药物制剂的制药公司ARS Pharmaceuticals, Inc.已修订了与Renaissance Lakewood, LLC的制造协议。该修订于周一生效，修改了原本于2020年9月9日签订并于2023年7月25日修订的协议条款。
bovnews2 天
ARS Pharmaceuticals Inc (SPRY) Stock’s 1.69% Increase This Year: What’s the Story?
ARS Pharmaceuticals Inc (SPRY) stock saw a decline, ending the day at $14.77 which represents a decrease of $-0.09 or -0.61% from the prior close of $14.86. The stock opened at $14.97 and touched a ...
美国现已推出治疗严重过敏的鼻喷剂
圣地亚哥 - 生物制药公司ARS Pharmaceuticals, Inc. (NASDAQ: SPRY)宣布,其处方药neffy®(肾上腺素鼻喷剂)现已在全美上市。美国食品药品监督管理局(FDA)上月批准了用于治疗体重超过30公斤(66磅)个体I型过敏反应(包括过敏性休克)的2毫克neffy。 通过neffyConnect项目和与在线药房BlinkRx的合作,符合条件的商业保险患者可以25美元的 ...
Monthly Prescribing Reference2 天
Epinephrine Nasal Spray Neffy Now Available to Treat Severe Allergic Reactions
Credit: ARS Pharmaceuticals. Neffy is indicated for adult and pediatric patients weighing at least 30kg. It is recommended that patients be prescribed and have immediate access to 2 neffy nasal sprays ...
The Schall Law Firm Urges Shareholder Participation In An Inquiry Into ARS Pharmaceuticals ...
NDAQ:SPRY) The Schall Law Firm Urges Shareholder Participation In An Inquiry Into ARS Pharmaceuticals Inc's Securities Law Violations ...
Singularity Hub4 天
This Week’s Awesome Tech Stories From Around the Web (Through September 21)
From a $100 billion AI investment to a cancer vaccine trial, check out this week's awesome tech stories from around the web.
Heath Headlines: Doctors developing vaccines in nasal spray form
Now, doctors and researchers are working on other vaccines that would be beneficial in nasal spray form. Dr. Curiel says ...
同花顺股票频道5 天
Leerink Partners：维持ARS Pharmaceuticals(SPRY.US)评级
Leerink Partners：维持ARS Pharmaceuticals(SPRY.US)评级，由优于大市调整至优于大市评级,目标价由21.00美元调整至25.00美元。 ARS Pharmaceuticals(SPRY.US)公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗I型过敏反应(包括过敏反应)的新型、潜在一流 ...
Rocket Report: Eutelsat’s surprising decision; Europe complains about SpaceX again
Iran launches Qaem-100 rocket again. After an initial failure in 2023, Iran has now successfully launched the small, solid ...
同花顺股票频道5 天
美股内部交易 | ARS Pharmaceuticals于9月19日披露6笔公司内部人交易情况
2024年9月19日， ARS Pharmaceuticals（SPRY）披露6笔公司内部人交易情况。持股10%以上股东Lowenthal Richard E于2024年9月18日卖出5.00万股。 2024年9月19日 高管 Karas Eric 2024年9月18日 买入 1.00万 1.50 1.50万 2024年9月19日 持股10%以上股东 Tanimoto Sarina ...